Filovirus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials

A Study to Evaluate Safety, Tolerability, and Immunogenicity of Heterologous Prime-boost Regimens Using the Multivalent Filovirus Vaccines Ad26.Filo and MVA-BN-Filo Administered in Different Sequences and Schedules in Healthy Adults
Condition:   Healthy Interventions:   Biological: Ad26.Filo;   Biological: MVA-BN-Filo;   Biological: Ad26.ZEBOV;   Biological: Placebo;   Biological: MVA-BN-Filo Sponsors:   Janssen Vaccines & Prevention B.V.;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2016 Category: Research Source Type: clinical trials